6-84736951-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_001080508.3(TBX18):āc.1558A>Gā(p.Thr520Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,608,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001080508.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX18 | NM_001080508.3 | c.1558A>G | p.Thr520Ala | missense_variant | 8/8 | ENST00000369663.10 | NP_001073977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX18 | ENST00000369663.10 | c.1558A>G | p.Thr520Ala | missense_variant | 8/8 | 1 | NM_001080508.3 | ENSP00000358677.4 | ||
TBX18 | ENST00000606784.5 | c.625+1546A>G | intron_variant | 1 | ENSP00000475873.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000647 AC: 16AN: 247336Hom.: 0 AF XY: 0.0000525 AC XY: 7AN XY: 133410
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1456932Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 724058
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151998Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74234
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.1558A>G (p.T520A) alteration is located in exon 8 (coding exon 8) of the TBX18 gene. This alteration results from a A to G substitution at nucleotide position 1558, causing the threonine (T) at amino acid position 520 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 520 of the TBX18 protein (p.Thr520Ala). This variant is present in population databases (rs537759635, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with TBX18-related conditions. ClinVar contains an entry for this variant (Variation ID: 2064043). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBX18 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at